EUVIMEDEUVIMED entdecken
Crossref

Expression of miR-34a, RASSF1A and E-cadherin in relation to PRB in endometrioid carcinoma and its precursor

Mona Mostafa Ahmed, Amr A Awd, Muhannad Mohamed Elsayed, Basma A Ibrahim, Hanim M Abdelnour

Medical Molecular Morphology · 2024

DOI: 10.1007/s00795-024-00397-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Molecular Morphology, 2024. Verfasst von Mona Mostafa Ahmed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Mostafamona90@yahoo.com. Hauptthemen laut MEDLINE: Cadherins, Tumor Suppressor Proteins, MicroRNAs, Carcinoma, Endometrioid. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current study aims to evaluate the levels of miR-34a, RASSF1A, and E-cadherin in relation to the levels of isoform B of progesterone receptor (PRB) in endometrioid carcinoma (EC) and atypical hyperplasia (AEH) and their association with clinicopathological parameters. 105 cases (35 EC, 35 AEH, and 35 control) were involved in this study. Cases of AEH received treatment, and other samples were obtained after 6 months to assess the response. E-cadherin and PRB were assessed by immunohistochemistry (IHC), RASSFA methylation by MSP-PCR, and its serum level by ELISA and miR-34a via quantitative PCR. The expressions of miR-34a, RASSF1A, E-cadherin, and PRB differ among the studied groups; all were higher in normal compared with AEH and EC, with a statistically significant difference. The higher PRB expression and decreased miR-34a and RASSF1A expression were associated with resistance to hormonal therapy in AEH. High PRB in EC is associated with lower RASSFA1, E-cadherin, and miR-34a. Decreased expressions of RASSF1A, miR-34a, and E-cadherin had a significant connection to advanced stages. Expression of PRB and miR-34a and serum levels of RASSF1A predict response to treatment in cases of AEH. High PRB and low E-cadherin expression are associated with progressive disease in EC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CadherinsTumor Suppressor ProteinsMicroRNAsCarcinoma, EndometrioidReceptors, ProgesteroneHumansFemaleMiddle AgedGene Expression Regulation, NeoplasticEndometrial NeoplasmsAntigens, CDAdultAgedDNA Methylation

Stichwörter der Autor:innen

E-cadherinEndometrial cancerPRBRASSF1AmiR-34a

Substanzen

CadherinsRASSF1 protein, humanMIRN34 microRNA, humanTumor Suppressor ProteinsMicroRNAsCDH1 protein, humanReceptors, ProgesteroneAntigens, CD

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Mostafamona90@yahoo.com.
  • Department of Gynecology and Obstetrics, Zagazig University, Zagazig, Egypt.
  • Department of Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Zitieren

APA

Ahmed, M. M., Awd, A. A., Elsayed, M. M., Ibrahim, B. A., & Abdelnour, H. M. (2024). Expression of miR-34a, RASSF1A and E-cadherin in relation to PRB in endometrioid carcinoma and its precursor. Medical Molecular Morphology. https://doi.org/10.1007/s00795-024-00397-w

Vancouver

Ahmed MM, Awd AA, Elsayed MM, Ibrahim BA, Abdelnour HM. Expression of miR-34a, RASSF1A and E-cadherin in relation to PRB in endometrioid carcinoma and its precursor. Medical Molecular Morphology. 2024. doi:10.1007/s00795-024-00397-w

BibTeX
@article{Ahmed2024,
  author = {Ahmed, Mona Mostafa and Awd, Amr A and Elsayed, Muhannad Mohamed and Ibrahim, Basma A and Abdelnour, Hanim M},
  title = {Expression of miR-34a, RASSF1A and E-cadherin in relation to PRB in endometrioid carcinoma and its precursor},
  journal = {Medical Molecular Morphology},
  year = {2024},
  doi = {10.1007/s00795-024-00397-w}
}
Kostenlos starten →